We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$36.5B
AUM Growth
+$3.93B
(+12%)
Cap. Flow
+$651M
Cap. Flow
% of AUM
1.78%
Top 10 Holdings %
Top 10 Hldgs %
7.68%
Holding
3,587
New
780
Increased
747
Reduced
671
Closed
866
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$223M |
| 2 |
TJX Companies
TJX
|
+$191M |
| 3 |
TransDigm Group
TDG
|
+$157M |
| 4 |
Ingersoll Rand
IR
|
+$155M |
| 5 |
BP
BP
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 2 |
Eaton
ETN
|
+$261M |
| 3 |
Union Pacific
UNP
|
+$252M |
| 4 |
Analog Devices
ADI
|
+$240M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.3% |
| 2 | Financials | 10.99% |
| 3 | Technology | 9.97% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Healthcare | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Paychex
PAYX
$42.8B
| $77K | ﹤0.01% |
666
-41,730
| -98% | -$4.88M |
|
2252
Inovio Pharmaceuticals
INO
$93M
| $75.9K | ﹤0.01% |
4,055
-1,389
| -26% | -$31.5K |
|
2253
Tanger
SKT
$4.42B
| $75.8K | ﹤0.01% |
4,224
-8,880
| -68% | -$159K |
|
2254
Wave Life Sciences
WVE
$1.02B
| $75.5K | ﹤0.01% |
+10,785
| New | +$49.7K |
|
2255
Acuity Brands
AYI
$10.8B
| $74.9K | ﹤0.01% |
452
-240,572
| -100% | -$42.7M |
|
2256
Microvision
MVIS
$89.7M
| $74.4K | ﹤0.01% |
+2,110
| New | +$98.1K |
|
2257
Nu Holdings
NU
$67.3B
| $73.9K | ﹤0.01% |
18,167
-949,059
| -98% | -$4.12M |
|
2258
Lexicon Pharmaceuticals
LXRX
$1.04B
| $73.3K | ﹤0.01% |
+38,377
| New | +$81.7K |
|
2259
Watsco Inc
WSO
$12.8B
| $73.1K | ﹤0.01% |
+293
| New | +$77K |
|
|
HIBB
2260
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $73.1K | ﹤0.01% |
+1,071
| New | +$66.8K |
|
2261
Amprius Technologies Warrants
AMPX.WS
$564M
| $72.5K | ﹤0.01% |
250,000
| – | – |
|
2262
Emcor
EME
$36.8B
| $72.1K | ﹤0.01% |
487
-8,025
| -94% | -$1.14M |
|
|
GTHX
2263
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $71.9K | ﹤0.01% |
+13,241
| New | +$111K |
|
2264
GE Aerospace
GE
$374B
| $71.6K | ﹤0.01% |
+1,372
| New | +$67.4K |
|
2265
Transocean
RIG
$6.39B
| $71.2K | ﹤0.01% |
15,603
-77,993
| -83% | -$301K |
|
2266
Talos Energy
TALO
$2.59B
| $71.1K | ﹤0.01% |
3,768
-29,312
| -89% | -$588K |
|
2267
Korn Ferry
KFY
$4.28B
| $70.3K | ﹤0.01% |
+1,389
| New | +$73.8K |
|
2268
Ocular Therapeutix
OCUL
$2.25B
| $70.2K | ﹤0.01% |
+24,991
| New | +$82.7K |
|
|
RENEW
2269
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
| $70K | ﹤0.01% |
400,000
| – | – |
|
|
AXON
2270
Axon Enterprise
AXON
$48.7B
| $69.5K | ﹤0.01% |
419
-24,468
| -98% | -$3.87M |
|
2271
Lightwave Logic
LWLG
$1.12B
| $69.5K | ﹤0.01% |
+16,127
| New | +$115K |
|
2272
Werner Enterprises
WERN
$2.31B
| $69K | ﹤0.01% |
1,713
-4,134
| -71% | -$169K |
|
|
AKTS
2273
DELISTED
Akoustis Technologies Inc
AKTS
| $68.2K | ﹤0.01% |
24,182
+4,520
| +23% | +$14.2K |
|
2274
UFP Industries
UFPI
$5.06B
| $67.9K | ﹤0.01% |
+857
| New | +$65.5K |
|
2275
Prothena Corp
PRTA
$475M
| $67.2K | ﹤0.01% |
1,115
-5,400
| -83% | -$316K |
|
Similar funds
BC
Balyasny Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Balyasny Asset Management held 3,587 positions worth $36.5B, up 12% from $32.6B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Balyasny Asset Management's Q4 2022 filing shows 780 new, 747 increased, 671 reduced and 866 closed positions. Its largest new stake was TJX Companies: 2,589,145 shares worth $206M. The largest sale was ZENDESK INC, an estimated $300M.
By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
- Balyasny Asset Management's largest Q4 2022 buy was TJX Companies: 2,589,145 shares worth $206M.
- Balyasny Asset Management added most to Visa in Q4 2022, an estimated $223M increase.
- Balyasny Asset Management's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $252M.
- Balyasny Asset Management fully exited ZENDESK INC in Q4 2022, selling an estimated $300M.
- Balyasny Asset Management's ten largest holdings make up 7.7% of its $36.5B portfolio in Q4 2022.
- Balyasny Asset Management opened 780 new positions and closed 866 in Q4 2022.
- Balyasny Asset Management's portfolio value rose 12% quarter-over-quarter to $36.5B.
Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.